Description: Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.
Home Page: www.aptorumgroup.com
APM Technical Analysis
17 Hanover Square
London,
W1S 1BN
United Kingdom
Phone:
44 20 8092 9299
Officers
| Name | Title |
|---|---|
| Mr. Darren Lui | CEO, Chief Accounting Officer & Exec. Director |
| Mr. Chung Yuen Huen | Founder & Non-Exec. Director |
| Dr. Clark Cheng | Chief Medical Officer & Exec. Director |
| Dr. Wai Yip Lee | Head of R&D |
| Mr. Martin Siu | Head of Fin. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8041 |
| Price-to-Sales TTM: | 12.4724 |
| IPO Date: | 2018-12-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 26 |